Sagicor Cayman, one of the leading providers of life insurance locally, has implemented measures to help clients cope during the ongoing coronavirus (COVID 19) pandemic.
Among the measures is encouragement for persons to utilise Client Web, a free and convenient platform that enables policyholders to have 24-hour access to information on their policies.
The company also provides a suite of payment options to ensure clients can safely maintain their policies. These include online payment through Cayman National Bank and bank-to-bank transfers through any local bank. Electronic payments via credit and debit cards are also facilitated when clients complete an authorization and indemnity form. This is available on the company’s website and may be emailed to firstname.lastname@example.org.
Other convenient methods of payment include dropping off or mailing cheques or bank drafts to the company’s offices at Sagicor House, Georgetown.
Mark Chisholm, President and CEO, Sagicor Cayman, said the company wishes to assure clients that it remains committed to responding to their needs at this time through the implementation of convenient avenues for them to interact with the company.
“At Sagicor, we want our clients to still be able reach us and access their benefits, despite disruptions currently, by taking advantage of advances in technology and the measures we have implemented to maintain accessibility,” he said.
Chisholm further reminded clients that full benefits remain intact, in the event that an insured succumbs to complications related to COVID 19 once all the contractual conditions for coverage are met.
In compliance with directives by the Government, the company has closed its offices, starting Wednesday, March 25, for 10 days or until further notice.
Clients who wish to get more information or make queries on their policies can reach out to the company by email at email@example.com. They are also encouraged to visit www.sagicorcayman.com to sign up for Client Web.
The COVID 19 vaccines have arrived. Will you take the Vaccine?